Effect of allergist intervention on patient-centered and societal outcomes: Allergists as leaders, innovators, and educators

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 6, 2000, Pages 995-1018

  Zeiger, Robert S ^a   Schatz, Michael ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Allergic rhinitis; Allergist interventions; Anaphylaxis; Asthma; Clinical trials; Drug allergy; Education; Food allergy

Indexed keywords

ALLERGIC RHINITIS; ALLERGY; ATOPY; DRUG HYPERSENSITIVITY; FOOD ALLERGY; HEALTH EDUCATION; HUMAN; IMMUNOMODULATION; MEDICAL SPECIALIST; PATIENT CARE; PRIORITY JOURNAL; REVIEW;

EID: 0034544752     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.110921     Document Type: Article

References (164)

1. Changing prevalence of asthma in Australian children
2. 20-Year trends in the prevalence of asthma and chronic airflow obstruction in an HMO
3. Changing prevalence of allergic rhinitis and asthma
4. Peanut allergy in relation to heredity, maternal diet, and other atopic diseases: Results of a questionnaire survey, skin prick testing, and food challenges
5. Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: Comparison with the disease frequency examined 20 years ago
6. Pathogenesis of atopic dermatitis
7. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC
8. Epidemiology of anaphylaxis in Olmsted County: A population-based study
9. Food allergy, I: Immunopathogenesis and clinical disorders
10. Food allergy, II: Diagnosis and management
11. Prevalance of allergy to Hymenoptera stings
12. The rising trend in allergic illness: Which environmental factors are important?
13. Development and prevention of allergic disease in childhood
14. Environmental factors and primary T-cell sensitisation to inhalant allergens in infancy: Reappraisal of the role of infections and air pollution
15. Reversing the trend: Reducing the prevalence of asthma
16. Surveillance for asthma - United States, 1960-1995
17. Births, marriages, divorces, and deaths for January 1997
18. Trends in pediatric asthma hospitalization rates: Regional and socioeconomic differences
19. Comprehensive asthma management: Guidelines for clinicians
20. International consensus report on the diagnosis and management of rhinitis
21. Cross-sectional analysis of the relationship between national guideline recommended asthma drug therapy and emergency/hospital use within a managed care population
22. Comparison of emergency room asthma care to National Guidelines
23. Prior diagnosis and treatment of patients with normal results of methacholine challenge and unexplained respiratory symptoms
24. Prescribing for childhood asthma in the Wellington area: Comparison with international guidelines
25. General practitioners' views of clinical guidelines for the management of asthma
26. Pediatric asthma care in the emergency department: Measuring the quality of history-taking and discharge planning
27. The use of objective measures of asthma severity in primary care: A report from ASPN
28. Effect of local standards on the implementation of national guidelines for asthma: Primary care agreement with national asthma guidelines
29. Adherence to asthma guidelines in general practices
30. A quality assurance review of outpatient care of children with life-threatening asthma exacerbations
31. Pediatricians' attitudes, beliefs, and practices regarding clinical practice guidelines: A national survey
32. The treatment of patients with asthma by specialists and generalists
33. Physicians' prevention-related practice behaviors in treating adult patients with asthma: Results of a national survey
34. Asthma: Benchmarking for quality improvement
35. Compliance with national asthma management guidelines and specialty care: A health maintenance organization experience
36. Preventive pharmacologic therapy among asthmatics: Five years after publication of guidelines
37. Asthma guidelines: An assessment of physician understanding and practice
38. Compliance with US asthma management guidelines and specialty care: A regional variation or national concern?
39. Effect of allergy specialist care on the quality of life in patients with asthma
40. Comparison of disease-specific and generic health-related quality of life (HRQOL) instruments in an allergy specialist clinic
41. Asthma care practices, perceptions, and beliefs of Chicago-area asthma specialists: Chicago Asthma Surveillance Initiative Project Team
42. Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: A critical review of the literature and proposed methodologic standards
43. Specialty differences in the treatment of asthma
44. Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits
45. Allergist influence on asthma care
46. Effectiveness of a specialized asthma clinic in reducing asthma morbidity in an inner-city minority population
47. Do specialists order too many tests? The case of allergists and pediatric asthma
48. Cost effectiveness of an allergy consultation in the management of asthma
49. Specialty differences in the management of asthma: A cross-sectional assessment of allergists' patients and generalists' patients in a large HMO
50. Care of asthma: Allergy clinic versus emergency room
51. Treatment patterns among adult patients with asthma: Factors associated with overuse of inhaled beta-agonists and underuse of inhaled corticosteroids
52. Superior clinical outcomes of inner city asthma patients treated in an allergy clinic
53. Outcomes evaluation of a comprehensive intervention program for asthmatic children enrolled in medicaid
54. Management of acute asthma: A survey of hospital practice and comparison between thoracic and general physicians in Birmingham and Manchester
55. Differences in hospital asthma management
56. Use of a guideline based questionnaire to audit hospital care of acute asthma
57. Results of a program to reduce admissions for adult asthma
58. Controlled trial of a home and ambulatory program for asthmatic children
59. Clustered randomised trial of an intervention to improve the management of asthma: Greenwich asthma study
60. Allergological examination in general practice and in the specialist field of allergology: A comparative study of the concordance between a group of general practitioners and the allergological specialised health care services to which they refer
61. Impact of asthma specialists on patient outcomes
62. Assessment of asthma severity in adults with asthma treated by family practitioners, allergists, and pulmonologists
63. Pulmonary and allergy subspecialty care in adults with asthma: Treatment, use of services, and health outcomes
64. Short-term holding room treatment of asthmatic children
65. The impact of status asthmaticus practice guidelines on patient outcome and physician behavior
66. A self-management program for adult asthma, I: Development and evaluation
67. Reduction in resource utilization by an asthma outreach program
68. Perinatal outcomes in the pregnancies of asthmatic women: A prospective controlled analysis
69. A self-management program for adult asthma, II: Cost-benefit analysis
70. Risk management in allergen immunotherapy
71. An economic evaluation of short-term inpatient rehabilitation for children with severe asthma
72. An intervention program to reduce the hospitalization cost of asthmatic patients requiring intubation
73. Reduction of environmental tobacco smoke exposure among asthmatic children: A controlled trial
74. Reduction of environmental tobacco smoke exposure in asthmatic children: A 2-year follow-up
75. Emergency management of asthma in children: Impact of NIH guidelines
76. Randomised comparison of guided self management and traditional treatment of asthma over one year
77. The consideration of immunotherapy in the treatment of allergic asthma
78. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled tirals
79. Efficacy of specific immunotherapy in allergic asthma: Myth or reality?
80. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology
81. A controlled trial of immunotherapy for asthma in allergic children
82. Immunotherapy in bronchial asthma
83. Utilization and cost of immunotherapy for allergic asthma and rhinitis
84. The role of cost-effectiveness analysis in health and medicine: Panel on cost-effectiveness in health and medicine
85. Effectively costing out options
86. Recommendations of the panel on cost-effectiveness in health and medicine
87. The value of hyposensitization therapy for bronchial asthma in children - A 14-year study
88. Preventive allergy treatment as part of allergy disease management
89. Allergen immunotherapy: A long-term perspective
90. Costs of hay fever in the United States in 1990
91. A cost of illness study of allergic rhinitis in the United States
92. Prevalence of allergic rhinitis in the United States
93. Ten-year prognosis for generalized infantile eczema
94. The economic impact of allergic rhinitis
95. The impact of allergic rhinitis on bronchial asthma
96. Referral pattern to the allergist for hay fever in a health-care system with open access to specialists
97. Treatment of chronic rhinitis by an allergy specialist improves quality of life outcomes
98. Long-term clinical efficacy of grass-pollen immunotherapy
99. Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany
100. Economic outcomes for the treatment of allergic rhinitis
101. Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index
102. Healthcare expenditures for sinusitis in 1996: Contributions of asthma, rhinitis, and other airway disorders
103. Sinusitis: Bench to bedside. Current findings, future directions
104. Sinusitis in an allergist's office: Analysis of 200 consecutive cases
105. Nearly fatal anaphylaxis following an insect sting
106. Fatal food-induced anaphylaxis
107. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults
108. Acute drug desensitization
109. Elective penicillin skin testing and amoxicillin challenge: Effect on outpatient antibiotic use, cost, and clinical outcomes
110. Venom immunotherapy: When to start, when to stop
111. The impact of Hymenoptera venom allergy on occupational activities
112. A medical-center-wide, multidisciplinary approach to the problem of natural rubber latex allergy
113. Idiopathic anaphylaxis: A clinical summary of 175 patients
114. Respiratory tract and food hypersensitivity
115. Food hypersensitivity and atopic dermatitis: Evaluation of 113 patients
116. Anaphylaxis and food hypersensitivity
117. Skin testing and food challenges for evaluation of food allergy
118. Summary and recommendations: Classification of gastrointestinal manifestations due to immunologic reactions to foods in infants and young children
119. Immunotherapy for food hypersensitivity
120. Food allergy: From biology toward therapy
121. Safe administration of the measles vaccine to children allergic to eggs
122. Safe administration of influenza vaccine to patients with egg allergy
123. Eczema and food hypersensitivity
124. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children: Pediatric Tacrolimus Study Group
125. Prevention of food allergy and atopic disease
126. Dietary aspects of food allergy: Prevention in infants and children
127. The development and prediction of atopy in high-risk children: Follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance
128. Allergen avoidance in infancy and allergy at 4 years of age
129. Prevention of asthma by ketotifen in infants with atopic dermatitis
130. Prevention of asthma with ketotifen in preasthmatic children: A three-year follow-up study
131. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: First results of ETAC: Early Treatment of the Atopic Child
132. Ragweed immunotherapy in adult asthma
133. The Childhood Asthma Management Program (CAMP): Design, rationale, and methods. Childhood Asthma Management Program Research Group
134. A randomized clinical trial to reduce asthma morbidity among innercity children: Results of the National Cooperative Inner-City Asthma Study
135. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma: Asthma Clinical Research Network
136. Methacholine challenge testing: Safety of low starting FEV1: Asthma Clinical Research Network (ACRN)
137. An evaluation of colchicine as an alternative to inhaled corticosteriods in moderate asthma: National Heart, Lung, and Blood Institute's Asthma Clinical Research Network
138. Relationship of indexer allergen exposure to skin test sensitivity in innercity children with asthma
139. Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes
140. Assessment of the Air-Watch lung function monitoring system: Asthma Clinical Research Network (ACRN)
141. Characteristics of inner-city children with asthma: The National Cooperative Inner-City Asthma Study
142. Design and methods of the National Cooperative Inner-City Asthma Study
143. Psychosocial characteristics of inner-city children with asthma: A description of the NCICAS psychosocial protocol. National Cooperative Inner-City Asthma Study
144. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children
145. The use of twice daily nedocromil sodium in the treatment of asthma
146. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma: ACCOLATE Asthma Trialists Group
147. A multicenter evaluation of the clinical benefits of cromolyn sodium aerosol by metered-dose inhaler in the treatment of asthma
148. The therapeutic index of newer H1-receptor antagonists
149. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma
150. Theophylline in asthma
151. Treatment of allergic asthma with monoclonal anti-IgE antibody: rhuMAb-E25 Study Group
152. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody
153. DNA immunization: A novel approach to allergen-specific immunotherapy